Patient-specific measurement of functional movement disorders

Patient-specific measurement of functional movement disorders - Patient-specific measurement of functional movement disorders

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON46241

Enrollment

Registered

2016-03-21

Start date

2016-08-13

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional movement disorders

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age > 18 - Functional movement disorder, according to Fahn criteria, as judged by a neurologist Or a neurological movement disorder, as judged by a neurologist. - Symptom duration > 1 year - capable of keeping an electronic diary five times a day and have acces to internet at 9.00; 12.00; 15.00; 18.00; 21.00

Exclusion criteria

Exclusion criteria: - current medical treatment with botulinum - psychological treatment in the previous 6 months

Design outcomes

Primary

Measure	Time frame
Contributing factors to objective (and/or) subjective symptom fluctuation in individual patients.	—

Secondary

Measure	Time frame
The following possible contributing factors will be studied: - Positive And Negative Affect Schedule (PANAS) - Physical activity - Fatigue - Attention (in terms of social or mental activities) - Personal factor Furthermore, to measure the effect of the study, patient will complete questionnaires on self-belief (General Self-Efficacy Scale), quality of life (EQ-5D), and clinical global impression (CGI)	—

Measure

Time frame

The following possible contributing factors will be studied: - Positive And Negative Affect Schedule (PANAS) - Physical activity - Fatigue - Attention (in terms of social or mental activities) - Personal factor Furthermore, to measure the effect of the study, patient will complete questionnaires on self-belief (General Self-Efficacy Scale), quality of life (EQ-5D), and clinical global impression (CGI)

—

Countries

Netherlands

Outcome results